SYBLEU INC.

PINK:SYBE USA Biotechnology
Market Cap
$583.74K
Market Cap Rank
#39848 Global
#12961 in USA
Share Price
$0.06
Change (1 day)
+0.00%
52-Week Range
$0.06 - $0.06
All Time High
$0.29
About

SYBLEU INC. intends to engage in the primarily in the acquisition, licensing, and development of regenerative medical applications. It develops medical applications up to the point of completion of Phase I and or Phase II clinical trials after which the company sell or license developed applications or advance the application to Phase III clinical trials. SYBLEU INC. was incorporated in 2020 and … Read more

SYBLEU INC. (SYBE) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of December 2023: 0.014x

Based on the latest financial reports, SYBLEU INC. (SYBE) has a cash flow conversion efficiency ratio of 0.014x as of December 2023.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-5.46K) by net assets ($-389.96K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

SYBLEU INC. - Cash Flow Conversion Efficiency Trend (2019–2022)

This chart illustrates how SYBLEU INC.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

SYBLEU INC. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of SYBLEU INC. ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for SYBLEU INC. (2019–2022)

The table below shows the annual cash flow conversion efficiency of SYBLEU INC. from 2019 to 2022.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2022-12-31 $-266.08K $-100.56K 0.378x +20.30%
2021-12-31 $-249.96K $-78.53K 0.314x -98.36%
2020-12-31 $-4.61K $-88.34K 19.147x -29.38%
2019-12-31 $-2.78K $-75.35K 27.113x --